Page 3 - Pharma eZine 140828
P. 3
Index
4 A biter pill to swallow: How the truth about health products is sugar-coated
6 Right to health or commercial interests?
8 Balancing proitability with paient protecion: An ethical dilemma
10 How can companies beneit from improving access to medicines?
12 Imperaive for managing risk in pharma
14 Merging to replace creaion: The great inancial race of the pharma industry
16 Can clinical trials in developing countries ever be completely ethical?
18 Sustaining compeiive advantage and brand value in the Chinese market
20 Threats to water security and how pharma companies can miigate risk
23 RepRisk Spotlight on: GlaxoSmithKline
Produced by RepRisk AG
Editor: Anna Tuson
Sub-editors: Stella Kenway, Alexandra Mihailescu Cichon, Alessandra Oglino
Contributors: Philipp Aeby, Robert C. Brears, Wim Leereveld, Silvia Mancini, Nicole Neghaiwi,
Robert Pojasek, Leesa Soulodre, Saniago Villa Chiappe
All rights reserved with RepRisk AG. No part of this e–Zine may be reproduced, stored in a retrieval sytem, or transmited,
in any form or by any means, without the prior permission, issued in wriing, of the copyright holders:
RepRisk AG, Stampfenbachstrasse 42, 8006 Zurich, Switzerland. Tel. +41 43 300 54 40 www.reprisk.com
ISSUE 6 Pharmaceuicals l 3
